Search Results - "Serrano Alcala, Alicia"

Prognostic Impact of the New CLL-IPI Index in a Single Center CLL Spanish Cohort by Ferrer Lores, Blanca, Navarro Cubells, Blanca, Serrano Alcala, Alicia, Castillo Martin, Ivan, Teruel Casasus, Anabel, Ballester Martinez, Sandra, Perez Martinez, Ariadna, Mauricio Campos, Ana, Castillo Valero, Inmaculada, Cano Gracia, Horacio, Solano Vercet, Carlos, Terol Casterá, María José

“…The hallmark for Chroniclymphocytic leukemia (CLL) is a highly variable clinical course. An international prognostic index (CLL-IPI) is a promising tool to…”
Get full text

Prognostic value of genetic alterations and 18 F-FDG PET/CT imaging features in diffuse large B cell lymphoma by Ferrer-Lores, Blanca, Lozano, Jose, Fuster-Matanzo, Almudena, Mayorga-Ruiz, Irene, Moreno-Ruiz, Paula, Bellvís, Fuensanta, Teruel, Ana B, Saus, Ana, Ortiz, Alfonso, Villamón-Ribate, Eva, Serrano-Alcalá, Alicia, Piñana, José L, Sopena, Pablo, Dosdá, Rosa, Solano, Carlos, Alberich-Bayarri, Ángel, Terol, María José

“…The current standard front-line therapy for patients with diffuse large-B cell lymphoma (DLBCL)-rituximab plus cyclophosphamide, doxorubicin, vincristine, and…”
Get full text

Prognostic value of genetic alterations and 18F-FDG PET/CT imaging features in diffuse large B cell lymphoma by Ferrer-Lores, Blanca, Lozano, Jose, Fuster-Matanzo, Almudena, Mayorga-Ruiz, Irene, Moreno-Ruiz, Paula, Bellvís, Fuensanta, Teruel, Ana B, Saus, Ana, Ortiz, Alfonso, Villamón-Ribate, Eva, Serrano-Alcalá, Alicia, Piñana, José L, Sopena, Pablo, Dosdá, Rosa, Solano, Carlos, Alberich-Bayarri, Ángel, Terol, María José

“…The current standard front-line therapy for patients with diffuse large-B cell lymphoma (DLBCL)—rituximab plus cyclophosphamide, doxorubicin, vincristine, and…”
Get full text